
### [MONDO:0015496](http://purl.obolibrary.org/obo/MONDO_0015496)
**Label:** macroglossia

**Subclasses:** [MONDO:0016478](http://purl.obolibrary.org/obo/MONDO_0016478) (Beckwith-Wiedemann syndrome due to 11p15 translocation/inversion), [MONDO:0019923](http://purl.obolibrary.org/obo/MONDO_0019923) (Beckwith-Wiedemann syndrome due to paternal uniparental disomy of chromosome 11), [MONDO:0016477](http://purl.obolibrary.org/obo/MONDO_0016477) (Beckwith-Wiedemann syndrome due to 11p15 microdeletion), [MONDO:0019875](http://purl.obolibrary.org/obo/MONDO_0019875) (Beckwith-Wiedemann syndrome due to 11p15 microduplication), [MONDO:0009331](http://purl.obolibrary.org/obo/MONDO_0009331) (isolated hemihyperplasia), [MONDO:0010265](http://purl.obolibrary.org/obo/MONDO_0010265) (Simpson-Golabi-Behmel syndrome type 2), [MONDO:0016476](http://purl.obolibrary.org/obo/MONDO_0016476) (Beckwith-Wiedemann syndrome due to CDKN1C mutation), [MONDO:0016475](http://purl.obolibrary.org/obo/MONDO_0016475) (Beckwith-Wiedemann syndrome due to imprinting defect of 11p15), [MONDO:0007927](http://purl.obolibrary.org/obo/MONDO_0007927) (congenital macroglossia), [MONDO:0007534](http://purl.obolibrary.org/obo/MONDO_0007534) (Beckwith-Wiedemann syndrome), [MONDO:0010731](http://purl.obolibrary.org/obo/MONDO_0010731) (Simpson-Golabi-Behmel syndrome), [MONDO:0007590](http://purl.obolibrary.org/obo/MONDO_0007590) (hemifacial hypertrophy), [MONDO:0016547](http://purl.obolibrary.org/obo/MONDO_0016547) (Beckwith-Wiedemann syndrome due to NSD1 mutation), [MONDO:0011723](http://purl.obolibrary.org/obo/MONDO_0011723) (hemifacial myohyperplasia), 

**Corr. equiv. classes:** [Orphanet:231120](http://www.orpha.net/ORDO/Orphanet_231120), [Orphanet:96193](http://www.orpha.net/ORDO/Orphanet_96193), [Orphanet:231130](http://www.orpha.net/ORDO/Orphanet_231130), [Orphanet:238613](http://www.orpha.net/ORDO/Orphanet_238613), [Orphanet:96076](http://www.orpha.net/ORDO/Orphanet_96076), [Orphanet:373](http://www.orpha.net/ORDO/Orphanet_373), [Orphanet:231117](http://www.orpha.net/ORDO/Orphanet_231117), [Orphanet:231127](http://www.orpha.net/ORDO/Orphanet_231127), [OMIM:153630](http://purl.obolibrary.org/obo/OMIM_153630), [OMIM:130650](http://purl.obolibrary.org/obo/OMIM_130650), [OMIM:300209](http://purl.obolibrary.org/obo/OMIM_300209), [Orphanet:2430](http://www.orpha.net/ORDO/Orphanet_2430), [Orphanet:141145](http://www.orpha.net/ORDO/Orphanet_141145), [OMIM:133900](http://purl.obolibrary.org/obo/OMIM_133900), [OMIM:312870](http://purl.obolibrary.org/obo/OMIM_312870), [Orphanet:141148](http://www.orpha.net/ORDO/Orphanet_141148), [OMIM:606773](http://purl.obolibrary.org/obo/OMIM_606773), [Orphanet:79022](http://www.orpha.net/ORDO/Orphanet_79022), [Orphanet:2128](http://www.orpha.net/ORDO/Orphanet_2128), [Orphanet:116](http://www.orpha.net/ORDO/Orphanet_116), [OMIM:235000](http://purl.obolibrary.org/obo/OMIM_235000), 

**Class expressions from DL-Learner:**

- [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 47.02%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 47.02%
- [HP:0011794](http://purl.obolibrary.org/obo/HP_0011794) (Embryonal renal neoplasm) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 45.91%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0011794](http://purl.obolibrary.org/obo/HP_0011794) (Embryonal renal neoplasm) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 45.91%
- [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 44.90%
- [HP:0011794](http://purl.obolibrary.org/obo/HP_0011794) (Embryonal renal neoplasm) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 43.99%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) and [HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology) 43.99%
- [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 42.38%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) 42.38%
- [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) and [HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology) 40.40%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) 39.82%
- [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 39.29%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) and [HP:0011794](http://purl.obolibrary.org/obo/HP_0011794) (Embryonal renal neoplasm) 39.29%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) 39.29%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) 39.29%


